Shanghai Conant Optical Co., Ltd. (HKG:2276)

Market Cap	20.54B +73.1%
Revenue (ttm)	2.43B +6.1%
Net Income	620.64M +30.2%
EPS	1.34 +16.8%
Shares Out	486.03M
PE Ratio	31.65
Forward PE	26.19
Dividend	0.41 (0.96%)
Ex-Dividend Date	Jun 15, 2026

Volume	1,929,000
Open	42.30
Previous Close	42.26
Day's Range	42.30 - 44.46
52-Week Range	28.60 - 66.50
Beta	0.32
Analysts	Strong Buy
Price Target	68.39 (+56.5%)
Earnings Date	Aug 5, 2026

About Shanghai Conant Optical

Shanghai Conant Optical Co., Ltd. manufactures and sells resin spectacle lenses in Mainland China, the Americas, Asia, Europe, Oceania, and Africa. The company offers personalized, customized, and standardized lenses, such as UV++ series, 1.74 series, single vison, student, progressive, hi-vex, business, specialty, and anti-fog lenses, as well as UV shield and gaming glasses. It also provides after-sales support services. The company serves spectacle lens brand owners and international ophthalmic optic companies. Shanghai Conant Optical Co., Lt...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1996
• Employees: 2,890
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2276

Financial Performance

In 2025, Shanghai Conant Optical's revenue was 2.19 billion, an increase of 6.08% compared to the previous year's 2.06 billion. Earnings were 557.72 million, an increase of 30.22%.

Financial numbers in CNY